NCT04642365
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04642365
Title A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors.
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | DNK | CAN | BEL | AUS

Facility Status City State Zip Country Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Peter Maccallum Cancer Institute Melbourne Victoria 3000 Australia Details
Cliniques Universitaires St-Luc Brussels 1200 Belgium Details
BC Cancer Agency - Vancouver Vancouver British Columbia V5Z 4E6 Canada Details
The Ottawa Hospital Cancer Centre Ottawa Ontario K2H 6C2 Canada Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
Rigshospitalet København Ø 2100 Denmark Details
Clinica Universitaria de Navarra Pamplona Navarre 31008 Spain Details
Vall d?Hebron Institute of Oncology (VHIO), Barcelona Barcelona 08035 Spain Details
Hospital Clinico Universitario de Valencia Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field